Here are the top 10 ASX 200 shares today

It was a joyful end to the trading week for ASX 200 investors this Friday.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a happy end to the trading week indeed for the S&P/ASX 200 Index (ASX: XJO) and ASX shares this Friday.

After having a fairly bumpy week, the ASX 200 went out in style today, recording a healthy rise of 1.29%, putting the index up to 7,279 points.

Today's pleasing performance follows an exceptionally strong night of trading over on the US markets last night.

The Dow Jones Industrial Average Index (DJX: .DJI) experienced a cracking session, rising by a robust 0.96%. The Nasdaq Composite Index (NASDAQ: .IXIC) fared almost as well, shooting up by 0.81%.

But time now to check out how the local markets ended the week with a deep dive into the different ASX sectors.

A woman has a big smile on her face as she gets green paint powder tipped all over her.

Image source: Getty Images

Winners and losers

The good mood on the markets was palpable this Friday, with every single sector recording a rise.

Leading the charge upwards were ASX mining stocks. The S&P/ASX 200 Materials Index (ASX: XMJ) had a rollicking time, exploding 2.54% higher.

Not quite as enthusiastic, but still pleasing was the tech space. The S&P/ASX 200 Information Technology Index (ASX: XIJ) romped home with its gain of 1.93%.

Matching that exuberance was ASX energy shares. The S&P/ASX 200 Energy Index (ASX: XEJ) shot up 1.68%.

Then we have gold stocks. The All Ordinaries Gold Index (ASX: XGD) was also in form, rising by a robust 1.18%.

Consumer discretionary shares were also invited to the party, evident by the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ)'s 1.09% climb.

Financials shares are our first sector to record a rise of under 1%. But no one will be complaining about the S&P/ASX 200 Financials Index (ASX: XFJ)'s lift of 0.97%.

The same could be said of ASX consumer staples stocks, with the S&P/ASX 200 Consumer Staples Index (ASX: XSJ) vaulting 0.84% higher.

Even the worst performers this Friday gave us some not-unpleasing rises. The S&P/ASX 200 Utilities Index (ASX: XUJ) crept up by 0.28%, while the next-worst-performing space – real estate investment trusts (REITs) – also eked out a gain. The S&P/ASX 200 A-REIT Index (ASX: XPJ) inched 0.33% higher by market close.

Top 10 ASX 200 shares countdown

We had some stunning gains among the top ten shares this Friday to mark the end of the week.

None more so than Syrah Resources Ltd (ASX: SYR). Syrah shares rocketed 8.18% to 59.5 cents apiece despite no fresh news from the company. Perhaps investors are giving Syrah a fitting sendoff before this share is kicked out of the ASX 200 on Monday.

Here's a look at the rest of today's ASX stars:

ASX-listed company Share price Price change
Syrah Resources Ltd (ASX: SYR) $0.595 8.18%
Chalice Mining Ltd (ASX: CHN) $2.95 6.12%
Washington H. Soul Pattinson and Co Ltd (ASX: SOL) $35.82 6.64%
Life360 Inc (ASX: 360) $9.25 6.69%
Telix Pharmaceuticals Ltd (ASX: TLX) $11.62 5.25%
Bellevue Gold Ltd (ASX: BGL) $1.51 4.86%
Champion Iron Ltd (ASX: CIA) $6.64 5.90%
Polynovo Ltd (ASX: PNV) $1.385 5.32%
Core Lithium Ltd (ASX: CXO) $0.40 5.26%
Sayona Mining Ltd (ASX: SYA) $0.11 4.76%

Our top 10 shares countdown is a recurring end-of-day summary to let you know which companies were making big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

Motley Fool contributor Sebastian Bowen has positions in Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360, PolyNovo, Telix Pharmaceuticals, and Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has positions in and has recommended Washington H. Soul Pattinson and Company Limited. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »

Man with rocket wings which have flames coming out of them.
Broker Notes

These ASX 200 shares could rise ~40% to 80%

Brokers are predicting big returns for these top shares. Here's what you need to know.

Read more »

3 children standing on podiums wearing Olympic medals.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lacklustre end to the trading week this Friday...

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Broker Notes

2 ASX 200 stocks that could rise 50%

Morgans thinks the market is undervaluing these shares.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Technology Shares

I was going to buy these ASX tech stocks. Now, I'm not so sure

When the facts change, so should our buying...

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Dollar sign in yellow with a red falling arrow in front of a graph, symbolising a falling share price.
Broker Notes

6 ASX 200 shares downgraded by brokers this week

Brokers have reduced their ratings on TechnologyOne, Macquarie, 4DMedical, and others this week.

Read more »